Skip to main content

Monkeypox Update

Statement made on 22 June 2022

Statement UIN HCWS130


The United Kingdom Health Security Agency (UKHSA) yesterday published its updated vaccination strategy in response to the current monkeypox outbreak.

Based on the currently available vaccine supply, UKHSA recommends that the available doses of the vaccine should be used for a selective vaccine strategy with the aim of interrupting transmission in the subset of individuals at increased risk. This approach is supported by the Joint Committee on Vaccination and Immunisation (JCVI).

Although anyone can contract monkeypox, data from the latest outbreak shows higher levels of transmission within, but not exclusive to, the social networks of gay, bisexual, and other men who have sex with men (GBMSM). Therefore, the updated strategy recommends that vaccination should be offered as soon as feasible to GBMSM at highest risk. Targeted pre-exposure vaccination is also recommended for others, including healthcare workers who are at high risk of exposure.

In view of the current epidemiology and vaccine supply available, wider vaccination in low risk GBMSM individuals or the general population is not advised at this time.

NHS England is due to set out details on how eligible people can get vaccinated shortly.

To see the full updated strategy, which includes details of the recommendations for both pre- and post-exposure vaccination, please visit Monkeypox outbreak: vaccination strategy - GOV.UK (

Linked statements

This statement has also been made in the House of Lords

Department of Health and Social Care
Monkeypox Update
Lord Kamall
Parliamentary Under Secretary of State (Minister for Technology, Innovation and Life Sciences)
Conservative, Life peer
Statement made 22 June 2022